FAQ
The Rise of CRISPR Technology
CRISPR technology is a rapidly growing component of the genetics industry. Here's what investors need to...
March 20th, 2020
FAQ
What is Genetics Investing?
Genetics investing drives research that may ultimately prevent major illnesses. That makes it one of the...
February 26th, 2020
Applied Genetic Technologies Prepares Offering After Trial Data
The company faced a share price decline last week, but is still up over 50 percent...
January 30th, 2020
BMO Kicks Off Coverage of 4 Biotech Players
Four firms in the biotech space will now receive coverage from the investor research arm of...
January 28th, 2020
23andMe Working on New Drug Based on Users’ Genetics
23andMe is teaming up with Spanish drugmaker Almirall to develop an antibody that treats certain inflammatory...
January 13th, 2020
5 Top Genetics News Stories of 2019
What caught the attention of readers in the genetics market this year? We've compiled a list...
December 10th, 2019
Alnylam Gets FDA Nod for Rare Disease Drug
The FDA's approval of Alnylam's Gilvaari treatment is the first approval of its kind for acute...
November 20th, 2019